The Peptide Salamandrin-I Modulates Components Involved in Pyroptosis and Induces Cell Death in Human Leukemia Cell Line HL-60

Amphibian secretions have been extensively investigated for the production of bioactive molecules. Salamandrin-I is an antioxidant peptide, isolated from the skin secretion of the fire salamander, that has induced no toxicity in microglia or erythrocytes. Importantly, the administration of antioxida...

Full description

Saved in:
Bibliographic Details
Main Authors: Amandda Évelin Silva-Carvalho (Author), Nakaly Natiely de Oliveira (Author), Julia Viana Lafetá Machado (Author), Daniel Carneiro Moreira (Author), Guilherme Dotto Brand (Author), José Roberto S. A. Leite (Author), Alexandra Plácido (Author), Peter Eaton (Author), Felipe Saldanha-Araujo (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c36b9f1aa6aa40a6836e96d0447c04dd
042 |a dc 
100 1 0 |a Amandda Évelin Silva-Carvalho  |e author 
700 1 0 |a Nakaly Natiely de Oliveira  |e author 
700 1 0 |a Julia Viana Lafetá Machado  |e author 
700 1 0 |a Daniel Carneiro Moreira  |e author 
700 1 0 |a Guilherme Dotto Brand  |e author 
700 1 0 |a José Roberto S. A. Leite  |e author 
700 1 0 |a Alexandra Plácido  |e author 
700 1 0 |a Peter Eaton  |e author 
700 1 0 |a Felipe Saldanha-Araujo  |e author 
245 0 0 |a The Peptide Salamandrin-I Modulates Components Involved in Pyroptosis and Induces Cell Death in Human Leukemia Cell Line HL-60 
260 |b MDPI AG,   |c 2023-07-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15071864 
500 |a 1999-4923 
520 |a Amphibian secretions have been extensively investigated for the production of bioactive molecules. Salamandrin-I is an antioxidant peptide, isolated from the skin secretion of the fire salamander, that has induced no toxicity in microglia or erythrocytes. Importantly, the administration of antioxidants may constitute an adequate therapeutic approach to cancer treatment. Here, with the purpose of better characterizing the therapeutic potential of salamandrin-I, we investigated whether this antioxidant peptide also exerts anticancer activity, using the human leukemia cell line HL-60 as a cancer model. Salamandrin-I treatment induced a significant reduction in HL-60 proliferation, which was accompanied by cell cycle arrest. Furthermore, the peptide-induced cell death showed a significant increase in the LDH release in HL-60 cells. The cellular toxicity exerted by salamandrin-I is possibly related to pyroptosis, since the HL-60 cells showed loss of mitochondrial membrane potential and hyperexpression of inflammasome components following the peptide treatment. This is the first demonstration of the anticancer potential of the salamandrin-I peptide. Such results are important, as they offer relevant insights into the field of cancer therapy and allow the design of future bioactive molecules using salamandrin-I as a template. 
546 |a EN 
690 |a antioxidant peptide 
690 |a salamandrin-I 
690 |a leukemia 
690 |a HL-60 
690 |a pyroptosis 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 7, p 1864 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/7/1864 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/c36b9f1aa6aa40a6836e96d0447c04dd  |z Connect to this object online.